arrow
M

Marlena Klaic

University of Melbourne
H指数:12
被引数:935

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Direct Oral Challenge for Penicillin Allergy: A Hospital Implementation Evaluation Via the International Network of Antibiotic Allergy Nations (iNAAN) Study

青霉素过敏的直接口服激发试验:通过国际抗生素过敏国家网络(iNAAN)研究进行的医院实施评估

2026-04-010
PREAI
Direct Oral Challenge for Penicillin Allergy: The International Network of Antibiotic Allergy Nations (iNAAN) Study

青霉素过敏的直接口服激发试验:抗生素过敏国家国际网络(iNAAN)研究

2026-04-011
PREAI
Moving together to facilitate equity and inclusion in research. The co-production of interventions for clinical trials to facilitate participation of people from ethnically diverse communities

共同促进研究中的公平和包容。共同制作临床试验干预措施,以促进来自不同种族社区的人们的参与

2026-01-200
OAAI
Implementability of a co-designed programme to increase tailored exercise to reduce falls in older people from culturally and linguistically diverse communities: protocol for a pilot randomised controlled trial

针对来自文化语言多元化社区老年人量身定制运动以减少跌倒的协同设计干预方案的实施性:一项试点随机对照试验方案

2025-11-180
OA
International Network of Antibiotic Allergy Nations (iNAAN): Protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge

国际抗生素过敏国家网络(iNAAN):一项类型2混合有效性-实施性多中心前瞻性队列和目标试验模拟研究方案,评估通过直接口服挑战进行青霉素脱敏标签的效果。

2025-09-050
OAAI
icuRESOLVE-D (Intensive Care Unit REcovery Solutions cO-Led through surVivor Engagement-Digital): Protocol for a multicentre randomised controlled trial of digital peer support for adult survivors of critical illness

icuRESOLVE-D(通过幸存者参与实现重症监护室恢复解决方案的数字-化):一项关于数字同伴支持对成年危重疾病幸存者进行多中心随机对照试验的方案

2025-08-140
PRE